SINGH SHAWN (CHIEF EXECUTIVE OFFICER) exercised options at VISTAGEN THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 5/16/2022ACC: 0001415889-22-004988
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
0.00
Net shares
Net seller
$100.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100K acquired · 100K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$1.00
Trade value
$100K
% of position
204.1%
5/12/2022
49K→149K
Total
Net shares
+100K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/12/2022 | M · Option Exercise | +100K | $1.00 | $100K | 204.1% | 49K | 149K |
| Total | +100K | $100K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
1
Held after
70K
Exercisable
—
5/12/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 5/12/2022 | M · Option Exercise | −100K | 1 | — | 70K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned26.23K
Total
26.23K indirect26.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.23K | Indirect |
| Total | 26.23K | 26.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported